SOURCE: World Street Fundamentals

September 19, 2011 09:00 ET

Factors Moving Markets, Worldwide View - Equity Research on VIVUS, Inc. and Arena Pharmaceuticals, Inc.

HONG KONG--(Marketwire - Sep 19, 2011) - Today, www.WorldStreetFundamentals.com released its industry report highlighting VIVUS, Inc. (NASDAQ: VVUS) and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA). Full fundamental and technical analysis is available at www.WorldStreetFundamentals.com/Reports.php?id=VVUS+ARNA.

Continued confidence in long-term U.S. debt is defying S&P's recent downgrade. Treasury yields continue at their lowest levels since January 1, 2011 as the market moved to "safe investments" weary of the storm clouds ahead. Winds can change however, as a last-minute move to save the U.S. from a historic default on its debt obligations. Attentions are now turned to the situation in Europe, with the health of the Euro in the balance; bankers are looking to prevent defaults on Italian and Spanish debt.

As a result of recent credit adjustments, opportunity is being marked for investors to take advantage of equities with high-margin and specialty products. Market-wise investors are carefully watching for value within equities boasting established pipelines and excellent growth prospects. As part of this process, the following companies have been introduced with initial research reports available online.

World Street Fundamentals has highlighted VIVUS, Inc. for its current position within the healthcare industry. VIVUS, Inc. is a biopharmaceutical company. The Company is engaged in development and commercialization of therapeutic drugs for large underserved markets, including obesity and related morbidities, such as sleep apnea and diabetes and men's sexual health. The entire report on VIVUS, Inc. (NASDAQ: VVUS) is available here: www.WorldStreetFundamentals.com/Report.php?id=VVUS.

World Street has featured Arena Pharmaceuticals, Inc. for its development within the healthcare industry. Arena Pharmaceuticals, Inc. (Arena) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. The entire report on Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is available here: www.WorldStreetFundamentals.com/Report.php?id=ARNA.

About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets.

Contact Information